BIOMAT Database Logo BIOMAT Database Logo

Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini. 1991

K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
First Laboratory of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, Japan.

A bioassay using dispersed pancreatic acini was used to measure fasting plasma cholecystokinin (CCK) concentrations in 105 patients with various kinds of gastrointestinal diseases, 17 patients with diabetes mellitus, and 6 healthy volunteers. High plasma CCK bioactivities were observed in patients with obstructive jaundice, choledocolithiasis, and primary biliary cirrhosis. Twenty-three samples with high CCK bioactivities were assayed by the same bioassay after the addition of a specific CCK antagonist and by a CCK radioimmunoassay in order to determine whether the high CCK-like bioactivity was due to circulating CCK or other factors. High CCK bioactivities were partially inhibited by the specific CCK antagonist, CR-1409, but the activities were not totally abolished. The residual bioactivities (not inhibited by CR-1409) correlated with plasma bile acid concentrations. The inhibitable CCK bioactivities correlated with plasma CCK levels obtained by radioimmunoassay. Although the bioassay using dispersed pancreatic acini has several advantages for measuring plasma CCK, this method overestimates CCK bioactivities in patients with high plasma bile acid concentrations.

UI MeSH Term Description Entries
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D011377 Proglumide A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Xylamide,Milid,Xilamide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile

Related Publications

K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Cholecystokinin-induced regulation of muscarinic receptor on dispersed pancreatic acini.
October 1990, Gastroenterologia Japonica,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Preparation of dispersed pancreatic acinar cells and dispersed pancreatic acini.
January 1985, Methods in enzymology,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Dispersed pancreatic acinar cells and pancreatic acini.
January 1990, Methods in enzymology,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Exocrine pancreatic function in obstructive jaundice rats: studies with isolated dispersed pancreatic acini.
October 1992, The Journal of surgical research,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
[Bioassay for plasma cholecystokinin bioactivity].
December 1991, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
3H-methyl scopolamine binding to dispersed pancreatic acini.
January 1981, Cell and tissue research,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
The effect of helodermin in rat dispersed pancreatic acini.
March 1995, Pancreas,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Assay for the cholecystokinin receptor on pancreatic acini.
January 1985, Methods in enzymology,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Kinetics of binding of cholecystokinin to pancreatic acini.
July 1988, The American journal of physiology,
K Miyasaka, and A Funakoshi, and M Matsumoto, and R Nakamura, and S Sakamoto, and H Sakai, and K Kitani
Maturation of cholecystokinin receptors in pancreatic acini of rats.
May 1986, The American journal of physiology,
Copied contents to your clipboard!